Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by C. Heemann
Circulating Levels of TNF Receptor II Are Prognostic for Patients With Peripheral T-Cell Non-Hodgkin Lymphoma
Clinical Cancer Research
Cancer Research
Oncology
Related publications
Prognostic Markers in Peripheral T-Cell Lymphoma
Current Hematologic Malignancy Reports
Cancer Research
Oncology
Hematology
Prognostic Value of Interim Positron Emission Tomography in Patients With Peripheral T-Cell Lymphoma
Oncologist
Cancer Research
Medicine
Oncology
The Prognostic Significance of Elevated Levels of Serum Ferritin Before Chemotherapy in Patients With Non-Hodgkin Lymphoma
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
Comorbidity as an Independent Prognostic Factor in Elderly Patients With Peripheral T-Cell Lymphoma
OncoTargets and Therapy
Oncology
Pharmacology
Management of Patients With Non-Hodgkin’s Lymphoma: Focus on Adoptive T-Cell Therapy
ImmunoTargets and Therapy
Allergy
Immunology
Prognostic Factors in HIV-positive Patients With Non-Hodgkin Lymphoma: A Peruvian Experience
Infectious Agents and Cancer
Cancer Research
Epidemiology
Oncology
Infectious Diseases
Autologous Peripheral Blood Stem Cell Transplantation in Children and Adolescents With Non‑Hodgkin Lymphoma
Oncology Letters
Cancer Research
Oncology
Anti-Cd19 Chimeric Antigen Receptor T Cells in Combination With Nivolumab Are Safe and Effective Against Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma
Frontiers in Oncology
Cancer Research
Oncology
Circulating Microparticles Are Prognostic Biomarkers in Advanced Non-Small Cell Lung Cancer Patients
Oncotarget
Oncology
